Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2023, Vol. 55 ›› Issue (4): 612-618. doi: 10.19723/j.issn.1671-167X.2023.04.007

Previous Articles     Next Articles

Choice of immediate breast reconstructive methods after modified radical mastectomy

Jian-xun MA1,You-chen XIA1,Bi LI1,*(),Hong-mei ZHAO2,Yu-tao LEI2,Xi BU1   

  1. 1. Department of Plastic Surgery, Peking University Third Hospital, Beijing 100191, China
    2. Department of General Surgery, Peking University Third Hospital, Beijing 100191, China
  • Received:2020-12-04 Online:2023-08-18 Published:2023-08-03
  • Contact: Bi LI E-mail:libi0377@sina.com

RICH HTML

 0   

PDF (PC)

61

Abstract:

Objective: To investigate the choice of immediate breast reconstructive methods and asso-ciated outcomes after modified radical mastectomy. Methods: Retrospective analysis of patients undergoing immediate breast reconstruction after modified radical mastectomy in Peking University Third Hospital from January 2009 to May 2019. The reconstructive methods were summarized, and the clinical outcomes and the safety of immediate breast reconstruction were evaluated. Results: One hundred and twenty-three patients were enrolled in this study. Different reconstructive methods were applied according to the clinical stage, the amount of skin removal, the size of contralateral breasts, the physical condition and the preference of the patients. Seventy-nine cases were performed with tissue expander/implant two-stage reconstruction, twenty-three cases received direct breast implant insertion, seven cases were applied for latissimus dorsi (LD) myocutaneous flap transfer combined with implant insertion, five cases were provided transverse rectus abdominis myocutaneous (TRAM) flap transfer, six cases underwent tissue expander/implant combined with endoscopic LD muscle flap transfer, and three cases chose tissue expander/deep inferior epigastric artery perforator (DIEP) flap transfer. The average follow-up time was (12.3±9.0) months (3.5-41.0 months). One patient with direct implant insertion had partial blood supply distur-bance of the mastectomy flap. One case had necrosis of distal end of TRAM zone Ⅳ. One patient with expander/DIEP reconstruction had partial fat liquefaction. And two cases had expander leakage at the end of the expansion period. The tumor local recurrence occurred in one patient, and the implant was finally removed. The outcomes were evaluated by Harris method, and 90.2% patients were good or above in shape evaluation. Among the patients with implant based reconstruction, there was no obvious capsular contracture, and most of the implants had good or fair mobility. Conclusion: It is safe and feasible of immediate breast reconstruction after modified radical mastectomy for appropriate cases. The reconstructive methods can be individualized according to the individual's different conditions. The appropriate reconstructive methods could achieve satisfactory results.

Key words: Breast neoplasms, Mastectomy, modified radical, Reconstructive surgical procedures

CLC Number: 

  • R655.8

Figure 1

Process of expander/implant breast reconstruction in patients receiving radiation Tissue expander is inserted immediately post-mastectomy, and chemothe-rapy is not affected by tissue expansion. Tissue expansion is completed when radiation is coming. In order to avoid affecting the effect of radiotherapy and minimize the retraction of expanded tissue, the volume of expander should be reduced to 300 mL. Stage Ⅱ surgery could be performed six months after radiation."

Table 1

Relevant information on immediate breast reconstruction of 123 patients"

Items n(%)
Methods of immediate breast reconstruction (n=123)
  Tissue expander / implant 79 (64.2)
  Implant 23 (18.7)
  LDMCF + implant 7 (5.7)
  Tissue expander / LDMF + implant 6 (4.9)
  TRAM 5 (4.1)
  Tissue expander / DIEP flap 3 (2.4)
Implant (n=115)
  Anatomical 108 (93.9)
  Round 7 (6.1)
Surgery on the contralateral breast (n=123)
  Breast augmentation with implant 4 (3.3)
  Breast augmentation with autologous fat 4 (3.3)
  Mastopexy 6 (4.9)
  Breast reduction 1 (0.8)
  None 108 (87.7)
Complication
  Leakage of expander 2 (2/88, 2.3)
  Blood supply disorder of chest wall skin 1 (1/123, 0.8)
  Fat necrosis of DIEP flap 1 (1/3, 33.3)
  Necrosis of distal end of TRAM zone Ⅳ 1 (1/5, 20.0)
Harris evaluation[7] (n=122)
  Perfect 16 (13.1)
  Good 94 (77.1)
  Fine 12 (9.8)
  Poor 0
Capsular contraction (n=114)
  Baker grade Ⅰ 8 (7.0)
  Baker grade Ⅱ 94 (82.5)
  Baker grade Ⅲ 12 (10.5)
  Baker grade Ⅳ 0
Prosthesis mobility (n=114)
  Excessive 0
  Good 18 (15.8)
  Fair 68 (59.6)
  Fixed 28 (24.6)

Figure 2

Immediate tissue expander/implant two-stage breast reconstruction after left mastectomy A, a 41-year-old woman, left breast cancer, preoperative view; B, immediate expander insertion was applied post-mastectomy; C, expansion was finished when the volume reached 430 mL; D, on the second stage, while the expander would change to the permanent implant, the right mastopexy would also be applied; E, nine months after the reconstruction."

Figure 3

Immediate breast reconstruction using transverse rectus abdominis myocutaneous flap after right mastectomy A, a 30-year-old woman, right breast cancer, preoperative view; B, transverse rectus abdominis myocutaneous (TRAM) flap was harvest immediately post-mastectomy; C, six months after the reconstruction."

Figure 4

Immediate breast reconstruction using latissimus dorsi myocutaneous flap with implant after left mastectomy A, a 35-year-old woman, left breast cancer, preoperative view; B, the design of left latissimus dorsi myocutaneous flap (LDMCF) during the operation; C, LDMCF transfer combined with implant insertion for immediate breast reconstruction post-mastectomy; D, twelve months after the reconstruction."

1 Chen JJ , Huang NS , Xue JY , et al. Current status of breast reconstruction in southern China: A 15-year, single institutional experience of 20 551 breast cancer patients[J]. Medicine (Baltimore), 2015, 94 (34): e1399.
doi: 10.1097/MD.0000000000001399
2 Zhang B , Song Q , Zhang B , et al. A 10-year (1999-2008) retro-spective multi-center study of breast cancer surgical management in various geographic areas of China[J]. Breast, 2013, 22 (5): 676- 681.
doi: 10.1016/j.breast.2013.01.004
3 陈琳, 欧阳熠烨, 孙晶晶, 等. 乳房缺失患者生活质量与乳房再造手术相关性的量化研究[J]. 中华整形外科杂志, 2019, 35 (3): 218- 224.
4 陈颖, 陈嘉健, 陈嘉莹, 等. 中国乳腺癌术后乳房重建现况调查报告[J]. 中华肿瘤杂志, 2014, 36 (11): 851- 857.
doi: 10.3760/cma.j.issn.0253-3766.2014.11.011
5 Yoon AP , Qi J , Brown DL , et al. Outcomes of immediate versus delayed breast reconstruction: Results of a multicenter prospective study[J]. Breast, 2018, 37, 72- 79.
doi: 10.1016/j.breast.2017.10.009
6 李比, 夏有辰, 张洁, 等. 组织扩张后行假体乳房再造的对称性处理[J]. 组织工程与重建外科杂志, 2015, 11 (2): 67- 68.
7 Harris JR , Levene MB , Svensson G , et al. Analysis of cosmetic results following primary radiation therapy for stages Ⅰ and Ⅱ carcinoma of the breast[J]. Int J Radiat Oncol Biol Phys, 1979, 5 (2): 257- 261.
doi: 10.1016/0360-3016(79)90729-6
8 Anbiyaiee A , Abouali Galeh Dari M , Anbiyaee O , et al. Breast reconstruction after mastectomy in women with breast cancer: A systematic and meta-analysis review[J]. World J Plast Surg, 2020, 9 (1): 3- 9.
9 Xavier Harmeling J , Kouwenberg CA , Bijlard E , et al. The effect of immediate breast reconstruction on the timing of adjuvant che-motherapy: A systematic review[J]. Breast Cancer Res Treat, 2015, 153 (2): 241- 251.
doi: 10.1007/s10549-015-3539-4
10 Yun JH, Diaz R, Orman AG. Breast reconstruction and radiation therapy[J]. Cancer Control, 2018, 25(1): 1073274818795489.
11 Bertozzi N , Pesce M , Santi P , et al. One-stage immediate breast reconstruction: A concise review[J]. Biomed Res Int, 2017, 2017, 6486859.
12 Colwell AS , Christensen JM . Nipple-sparing mastectomy and direct-to-implant breast reconstruction[J]. Plast Reconstr Surg, 2017, 140 (5S Advances in Breast Reconstruction): 44S- 50S.
13 Kalus R , Dixon Swartz J , Metzger SC . Optimizing safety, predic-tability, and aesthetics in direct to implant immediate breast reconstruction: Evolution of surgical technique[J]. Ann Plast Surg, 2016, 76 (Suppl 4): S320- S327.
14 Ilonzo N , Tsang A , Tsantes S , et al. Breast reconstruction after mastectomy: A ten-year analysis of trends and immediate postope-rative outcomes[J]. Breast, 2017, 32, 7- 12.
doi: 10.1016/j.breast.2016.11.023
15 Frey JD , Choi M , Salibian AA , et al. Comparison of outcomes with tissue expander, immediate implant, and autologous breast reconstruction in greater than 1 000 nipple-sparing mastectomies[J]. Plast Reconstr Surg, 2017, 139 (6): 1300- 1310.
doi: 10.1097/PRS.0000000000003340
16 单秀英, 徐丽丽, 郑厚兵, 等. 组织扩张后假体置入同期脂肪移植乳房再造[J]. 中华整形外科杂志, 2019, 35 (3): 243- 247.
17 马建勋, 夏有辰, 李比, 等. 组织扩张结合假体乳房重建的技术改进[J]. 北京大学学报(医学版), 2020, 52 (1): 169- 176.
18 Mushin OP , Myers PL , Langstein HN . Indications and controversies for complete and implant-enhanced latissimus dorsi breast reconstruction[J]. Clin Plast Surg, 2018, 45 (1): 75- 81.
doi: 10.1016/j.cps.2017.08.006
19 Sood R, Easow JM, Konopka G, et al. Latissimus dorsi flap in breast reconstruction: Recent innovations in the workhorse flap[J]. Cancer Control, 2018, 25(1): 1073274817744638.
20 Ma JX , Li B , Xia YC , et al. Latissimus dorsi muscle flap transfer through endoscopic approach combined with the implant after tissue expansion for breast reconstruction of mastectomy patients[J]. BMC Surg, 2022, 22 (1): 10.
doi: 10.1186/s12893-021-01464-0
21 Murphy BD , Kerrebijn I , Farhadi J , et al. Indications and controversies for abdominally-based complete autologous tissue breast reconstruction[J]. Clin Plast Surg, 2018, 45 (1): 83- 91.
[1] Yun-jing ZHANG,Li-ying QIAO,Meng QI,Ying YAN,Wei-wei KANG,Guo-zhen LIU,Ming-yuan WANG,Yun-feng XI,Sheng-feng WANG. Development and validation of risk prediction model for new-onset cardiovascular diseases among breast cancer patients: Based on regional medical data of Inner Mongolia [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 471-479.
[2] Yue WANG,Shuang ZHANG,Hong ZHANG,Li LIANG,Ling XU,Yuan-jia CHENG,Xue-ning DUAN,Yin-hua LIU,Ting LI. Clinicopathological features and prognosis of hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 853-862.
[3] Wei ZUO,Fei GAO,Chang-wei YUAN,Sheng-wei XIONG,Zhi-hua LI,Lei ZHANG,Kun-lin YANG,Xin-fei LI,Liang LIU,Lai WEI,Peng ZHANG,Bing WANG,Ya-ming GU,Hong-jian ZHU,Zheng ZHAO,Xue-song LI. Trends in upper urinary tract reconstruction surgery over a decade based on a multi-center database [J]. Journal of Peking University (Health Sciences), 2022, 54(4): 692-698.
[4] LAN Lin,HE Yang,AN Jin-gang,ZHANG Yi. Relationship between prognosis and different surgical treatments of zygomatic defects: A retrospective study [J]. Journal of Peking University (Health Sciences), 2022, 54(2): 356-362.
[5] Si-da CHENG,Xin-fei LI,Sheng-wei XIONG,Shu-bo FAN,Jie WANG,Wei-jie ZHU,Zi-ao LI,Guang-pu DING,Ting YU,Wan-qiang LI,Yong-ming SUN,Kun-lin YANG,Lei ZHANG,Han HAO,Xue-song LI,Li-qun ZHOU. Robot-assisted laparoscopic upper urinary tract reconstruction surgery: A review of 108 cases by a single surgeon [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 771-779.
[6] Guo-hong SONG,Hui-ping LI,Li-jun DI,Ying YAN,Han-fang JIANG,Ling XU,Dong-gui WAN,Ying LI,Mo-pei WANG,Yu XIAO,Ru-yan ZHANG,Ran RAN,Huan WANG. Efficacy and safety of oral pyrotinib in HER2 positive metastatic breast cancer: real-world practice [J]. Journal of Peking University (Health Sciences), 2020, 52(2): 254-260.
[7] KANG Lei, HUO Yan, WANG Rong-fu, ZHANG Chun-li, YAN Ping, XU Xiao-jie. In vivo imaging of breast tumors by a 99mTc radiolabeled probe targeting microRNA-155 in mice models [J]. Journal of Peking University(Health Sciences), 2018, 50(2): 326-330.
[8] ZHU Yan，SHI Yong-jin，ZHAO Yu-liang, ZHU Ping. Topoisomerase inhibitor upregulates MICA/B expression in breast cancer cells through ATM/ATR and NF-κB pathway [J]. Journal of Peking University(Health Sciences), 2018, 50(2): 318-325.
[9] LI Xiu-nan, LIU Ai-hui, TANG Xin, REN Yu. Urothelial carcinoma-associated 1 enhances tamoxifen resistance in breast cancer cells through competitively inhibiting miR-18a [J]. Journal of Peking University(Health Sciences), 2017, 49(2): 295-302.
[10] SHAO Bin, LI Hui-ping， DI Li-jun, SONG Guo-hong, JIANG Han-fang, LIANG Xu, WANG Chao-ying, YAN Ying, LIN Xiao-lin, WANG Li-na, WAN Feng-ling, YUAN Yan-hua, YOU Miao-ning. Predictive and prognostic value of monitoring lymphocyte subsets in peripheral blood before and after chemotherapy in patients with metastatic breast cancer [J]. Journal of Peking University(Health Sciences), 2016, 48(2): 304-309.
[11] ZHANG Hui, LIU Xin, HONG Lei, GENG Xiang-su, FENG Hua. Arthroscopic all-inside reconstruction for posterior cruciate ligament and popliteus tendon compared with popliteofibular ligament reconstruction: clinical outcome of minimum 2-year follow-up [J]. Journal of Peking University(Health Sciences), 2016, 48(2): 237-243.
[12] LIAO Xiao-Xing, XING Nian-Zeng, QIAO Peng, KANG Ning, ZHANG Jun-Hui, NIU Yi-Nong. "Sandwich” urethra reconstruction improves the early continence following laparoscopic radical prostatectomy [J]. Journal of Peking University(Health Sciences), 2015, 47(4): 601-604.
[13] YU Sen, WANG Yang, MAO Chi, GUO Chuan-Bin, YU Guang-Yan, PENG Xin. Classification and reconstruction of 1 107 cases of maxillary defects [J]. Journal of Peking University(Health Sciences), 2015, 47(3): 509-513.
[14] TONG De-Di, CHEN Shan-Lin, RONG Yan-Bo, WU Le-Hao, ZHU Shan. Clinical application of lateral great toe flap in decoratively reconstruction of thumb pulp defect [J]. Journal of Peking University(Health Sciences), 2015, 47(2): 326-329.
[15] LI Feng-Long, JIANG Chun-Yan, LU Yi, ZHU Yi-Ming, LI Xu. Arthroscopic coracoclavicular ligament reconstruction versus open modified Weaver-Dunn procedure for acromioclavicular joint dislocations：comparison of curative effect [J]. Journal of Peking University(Health Sciences), 2015, 47(2): 253-257.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd